Lung Cancer

Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.

Original research articles, early reports, review articles and editorials covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are all welcome. Letters to the journals are also welcomed although authors should be aware that the majority will be published online only. Early reports should briefly describe the initial results of a research topic and will be expedited through peer-review.

Manuscripts describing studies on cell lines will only be considered if the data compares at least two types of distinct cell lines and the results have general implications on the understanding of the biology of chest tumours. Authors of studies on cell lines must also agree to make freely available to other researchers any of the cells, clones of cells, or DNA or antibodies, etc, that were used in the research reported and that are not available from commercial suppliers.

Editor in Chief: Rolf Stahel, Zurich, Switzerland
Organizational Affiliations: European Society for Medical Oncology Associazione Italiana di Oncologia Toracica The International Lung Cancer Consortium The European Thoracic Oncology Platform The British Thoracic Oncology Group  
2023
Online Only
Lung Cancer
Global Print Circulation
Online Only
Avg. Global Monthly Visits
12,656
Avg. Global Monthly Unique Visitors
10,509
Avg. Global Monthly Page Views
20,435
Avg. Global eTOC Distribution
2,830
Online Only eTOC Metrics: 6 Month Average of eTOC sends - Nov 2022 to April 2023

Contacts

Display Advertising

Recruitment Advertising

Have a question or need assistance?

Contact us now and a Sales Representative will be in touch.